Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Installed Building Products
IBP
$6.54B
| $2.7M | ﹤0.01% |
51,200
+19,100
| +60% | +$859K |
|
2077
Primis Financial Corp
FRST
$413M
| $2.7M | ﹤0.01% |
159,298
-4,602
| -3% | -$76K |
|
|
WHLR
2078
Wheeler Real Estate Investment Trust
WHLR
$383K
| – | – |
0
| – | – |
|
|
PKD
2079
DELISTED
Parker Drilling Company
PKD
| $2.69M | ﹤0.01% |
102,600
+16,380
| +19% | +$538K |
|
2080
Nu Skin
NUS
$236M
| $2.68M | ﹤0.01% |
48,300
-151,800
| -76% | -$7.82M |
|
|
LORL
2081
DELISTED
Loral Space and Communications, Inc.
LORL
| $2.68M | ﹤0.01% |
68,100
-95,509
| -58% | -$3.82M |
|
2082
State Street Health Care Select Sector SPDR ETF
XLV
$44B
| $2.66M | ﹤0.01% |
+35,800
| New | +$2.61M |
|
2083
Hallador Energy
HNRG
$730M
| $2.66M | ﹤0.01% |
332,200
+159,700
| +93% | +$1.41M |
|
|
ECOM
2084
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $2.65M | ﹤0.01% |
238,076
+111,276
| +88% | +$1.37M |
|
|
MGIC
2085
DELISTED
Magic Software Enterprises
MGIC
| $2.65M | ﹤0.01% |
340,152
-5,800
| -2% | -$43.2K |
|
2086
VanEck Oil Services ETF
OIH
$1.95B
| $2.65M | ﹤0.01% |
+4,305
| New | +$2.8M |
|
2087
Q2 Holdings
QTWO
$4.13B
| $2.65M | ﹤0.01% |
+76,000
| New | +$2.53M |
|
|
WSTL
2088
DELISTED
Westell Technologies Inc
WSTL
| $2.64M | ﹤0.01% |
943,357
+25,225
| +3% | +$68.9K |
|
|
AY
2089
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $2.64M | ﹤0.01% |
+125,900
| New | +$2.65M |
|
|
NXGN
2090
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $2.64M | ﹤0.01% |
173,157
-85,719
| -33% | -$1.26M |
|
2091
Lakeland Financial Corp
LKFN
$1.56B
| $2.63M | ﹤0.01% |
60,951
-10,449
| -15% | -$467K |
|
2092
Aclaris Therapeutics
ACRS
$863M
| $2.63M | ﹤0.01% |
88,079
-86,521
| -50% | -$2.49M |
|
2093
Protalix BioTherapeutics
PLX
$190M
| $2.62M | ﹤0.01% |
192,750
+144,820
| +302% | +$1.3M |
|
2094
Alnylam Pharmaceuticals
ALNY
$30.4B
| $2.62M | ﹤0.01% |
+51,100
| New | +$2.36M |
|
2095
CSP Inc
CSPI
$84.2M
| $2.62M | ﹤0.01% |
502,600
+16,000
| +3% | +$80.9K |
|
2096
Champion Homes
SKY
$5.23B
| $2.62M | ﹤0.01% |
277,800
-46,400
| -14% | -$510K |
|
2097
Scansource
SCSC
$1.06B
| $2.6M | ﹤0.01% |
+66,210
| New | +$2.7M |
|
|
ONDK
2098
DELISTED
On Deck Capital, Inc.
ONDK
| $2.6M | ﹤0.01% |
515,000
-261,800
| -34% | -$1.31M |
|
2099
Capital City Bank Group
CCBG
$898M
| $2.6M | ﹤0.01% |
121,299
+6,400
| +6% | +$131K |
|
2100
Boyd Gaming
BYD
$6.05B
| $2.58M | ﹤0.01% |
117,000
-92,400
| -44% | -$1.88M |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.